Wharton’s jelly mesenchymal stem cells transplantation for critical limb ischemia in patients with type 2 diabetes mellitus: a preliminary report of phase I clinical trial

Ashoobi, Mohammad Taghi; Hemmati, Hossein; Aghayan, Hamid Reza; Zarei-Behjani, Zeinab; Keshavarz, Samaneh; Babaloo, Hamideh; Maroufizadeh, Saman; Yousefi, Saeed; Farzin, Mohaya; Vojoudi, Elham

doi:10.1007/s00441-023-03854-7

Cell Tissue Res

2023

DOI: 10.1007/s00441-023-03854-7

|View full text |Cite

Wharton’s jelly mesenchymal stem cells transplantation for critical limb ischemia in patients with type 2 diabetes mellitus: a preliminary report of phase I clinical trial

Mohammad Taghi Ashoobi,

Hossein Hemmati,

Hamid Reza Aghayan

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Current Non-Surgical Curative Regenerative Therapies for Knee Osteoarthritis

Bahari Golamkaboudi,

Vojoudi,

Babaeian Roshani

et al. 2024

Stem Cell Rev and Rep

View full text Add to dashboard Cite

Current Non-Surgical Curative Regenerative Therapies for Knee Osteoarthritis

Bahari Golamkaboudi,

Vojoudi,

Babaeian Roshani

et al. 2024

Stem Cell Rev and Rep

View full text Add to dashboard Cite

Viabilidade do controle glicêmico no Diabetes Mellitus Tipo 2 com células-tronco mesenquimais: revisão integrativa

Gaião,

Silva,

Gomes

et al. 2024

Cad. Pedagógico

View full text Add to dashboard Cite

A diabetes mellitus tipo 2 (DM2) é uma condição metabólica caracterizada principalmente pela resistência à insulina e pelo aumento dos níveis de glicose no sangue. As células-tronco mesenquimais (CTMs) são células multipotentes com capacidade de diferenciação em tecidos mesenquimais e possivelmente não mesenquimais, destacando-se por sua plasticidade e propriedades imunomoduladoras. Diante desse contexto, com essa revisão de literatura no formato integrativo objetivo-se selecionar material literário nas bases de dados Nacional Library of Medicine (PubMed), Medical Literature Analysis and Retrieval Sistem on-line (MEDLINE via Biblioteca Virtual de Saúde), Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILCAS via Biblioteca Virtual de Saúde) e Scopus, para explorar o impacto do uso de células-tronco mesenquimais no controle glicêmico de indivíduos com DM2. De acordo com os resultados, as CTMs mostraram-se como uma opção segura na terapia celular em indivíduos com DM2. No entanto, pesquisas adicionais são necessárias para avaliar a sua utilização e possíveis impactos a longo prazo.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Wharton’s jelly mesenchymal stem cells transplantation for critical limb ischemia in patients with type 2 diabetes mellitus: a preliminary report of phase I clinical trial

Cited by 2 publications

References 41 publications

Current Non-Surgical Curative Regenerative Therapies for Knee Osteoarthritis

Current Non-Surgical Curative Regenerative Therapies for Knee Osteoarthritis

Viabilidade do controle glicêmico no Diabetes Mellitus Tipo 2 com células-tronco mesenquimais: revisão integrativa

Contact Info

Product

Resources

About